跳至主要内容
临床试验/NL-OMON47470
NL-OMON47470尚未招募2 期

Comparison of the beta cell mass during and shortly after the honeymoon phase of type 1 diabetes using Ga-68-exendin PET - GLP1-honeymoon

Radboud Universitair Medisch Centrum0 个研究点目标入组 18 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 64(—)

入选标准

  • honeymoon phase
  • - Age >=16 years
  • - Subject is diagnosed with type 1 diabetes (T1D)
  • - Presence of anti-GAD (glutamic acid decarboxylase)
  • - Subject is in the honeymoon phase of T1D: IDAA1c <9
  • - 17<= BMI <=30 kg/m^2 at the moment of the first visit
  • - Ability to sign informed consent

排除标准

  • - Previous treatment (within 6 months) with synthetic Exendin (Exenatide, Byetta®) or Dipeptidyl-Peptidase IV inhibitors
  • - Liver disease defined as aspartate aminotransferase or alanine aminotransferase level of more than 3 times the upper limit of normal range
  • - Renal disease defined as MDRD <40 ml/min/1.73m^2
  • - Pregnancy or the wish to become pregnant within 6 months after the study
  • - Breastfeeding
  • - BMI <17 kg/m^2 or BMI >30 kg/m^2
  • - Age <16 years
  • - When the end of the honeymoon phase (IDAA1c >=9) is not observed within 11 to 13 months after the inclusion of the subject
  • - Inability to sign informed consent

研究者

相似试验